TMO Chart

1 Month

	Date	Diff	Articles
	2025-05-05	-0.3 %	Thermo Fisher Scientific (TMO) stock declined by 0.3% as biotech stocks, including TMO, are experiencing volatility due to high investment in early-stage research and lengthy regulatory approval processes.
Thermo Fisher Scientific (TMO) stock declined by 0.3% as biotech stocks, including TMO, are experiencing volatility due to high investment in early-stage research and lengthy regulatory approval processes.
	2025-05-02	+0.87 %	Thermo Fisher Scientific's stock (TMO) rose by 0.87% despite multiple analysts cutting their price targets, indicating investor confidence was bolstered by the company's stronger-than-expected quarterly earnings and its dividend increase, alongside a generally favorable rating consensus.
Thermo Fisher Scientific's stock (TMO) rose by 0.87% despite multiple analysts cutting their price targets, indicating investor confidence was bolstered by the company's stronger-than-expected quarterly earnings and its dividend increase, alongside a generally favorable rating consensus. Thermo Fisher Scientific (TMO) stock rose by 0.87% due to the increasing demand for rapid and low-cost diagnostic tests for mpox, following the ongoing outbreaks and the urgent need for effective diagnostic tools highlighted by a recent study.
	2025-05-01	-2.12 %	Thermo Fisher Scientific (TMO) stock fell 2.12% last night, indicating potential investor concerns driven by overall market conditions affecting pharmaceutical stocks, particularly factors like competitive pressures and shifting regulations impacting the sector.
Thermo Fisher Scientific (TMO) stock fell 2.12% last night, indicating potential investor concerns driven by overall market conditions affecting pharmaceutical stocks, particularly factors like competitive pressures and shifting regulations impacting the sector. Thermo Fisher Scientific (TMO) stock declined by 2.12% because it was trading significantly below its recent moving averages, indicating potential investor concerns about its recent valuation and earnings outlook amid high trading volume in the biotech sector.
	2025-04-30	+0.34 %	Thermo Fisher Scientific (TMO) stock rose by 0.34% due to a positive earnings report that exceeded analysts’ expectations, alongside the announcement of a quarterly dividend increase.
Thermo Fisher Scientific (TMO) stock rose by 0.34% due to a positive earnings report that exceeded analysts’ expectations, alongside the announcement of a quarterly dividend increase. The article discusses various political and economic topics, noting a 0.34% rise in Thermo Fisher Scientific (TMO) stock, which is attributed to the successful appointment of Peter Nomikos' Capstone Capital as the largest shareholder of the Cooperative Bank of Epirus, signaling investor confidence and future growth potential for TMO. The article highlights that Thermo Fisher Scientific (TMO) experienced a slight increase of 0.34% in its stock price, attributed to being one of the top industrial stocks to watch due to high trading volume.
	2025-04-29	+1.47 %	Thermo Fisher Scientific (TMO) stock rose by 1.47% following favorable Q1 2026 earnings estimates from analysts at Leerink Partners, indicating positive expectations for the company's financial performance and reinforcing its strong market position despite some analysts lowering their price targets.
Thermo Fisher Scientific (TMO) stock rose by 1.47% following favorable Q1 2026 earnings estimates from analysts at Leerink Partners, indicating positive expectations for the company's financial performance and reinforcing its strong market position despite some analysts lowering their price targets.
	2025-04-28	-0.68 %	Thermo Fisher Scientific (TMO) stock declined by 0.68% to $424.02, potentially driven by broader market trends affecting biotech stocks or investor reactions to trading volumes and valuation metrics, especially as its recent trading was well below its 50-day and 200-day moving averages.
Thermo Fisher Scientific (TMO) stock declined by 0.68% to $424.02, potentially driven by broader market trends affecting biotech stocks or investor reactions to trading volumes and valuation metrics, especially as its recent trading was well below its 50-day and 200-day moving averages. Thermo Fisher Scientific (TMO) stock fell by 0.68% after Scotiabank lowered its target price from $650.00 to $605.00, indicating potential concerns about the company's performance amidst mixed analyst ratings and significant insider stock sales. Thermo Fisher Scientific (TMO) stock declined by 0.68% due to a downgrade from StockNews.com from a buy rating to a hold rating, as well as lowered price targets from several other analysts.
	2025-04-25	-0.57 %	Thermo Fisher Scientific (TMO) stock fell by 0.57%, and the decline could be attributed to general market trends affecting pharmaceutical stocks, influenced by factors like clinical trial outcomes, regulatory challenges, and overall market sentiment towards healthcare equities.
Thermo Fisher Scientific (TMO) stock fell by 0.57%, and the decline could be attributed to general market trends affecting pharmaceutical stocks, influenced by factors like clinical trial outcomes, regulatory challenges, and overall market sentiment towards healthcare equities.
	2025-04-24	-1.15 %	Thermo Fisher Scientific (TMO) stock experienced a decline of -1.15% amid a broader volatility in the biotech sector influenced by high research and development costs, regulatory challenges, and the overall market sentiment.
Thermo Fisher Scientific (TMO) stock experienced a decline of -1.15% amid a broader volatility in the biotech sector influenced by high research and development costs, regulatory challenges, and the overall market sentiment. Thermo Fisher Scientific (TMO) stock declined by 1.15% to $421.10 amid a broader market trend affecting industrial stocks, likely influenced by cyclical behavior and changes in investor sentiment regarding the economic environment. Thermo Fisher Scientific (TMO) stock fell by -1.15% due to factors that often affect pharmaceutical companies, such as potential market volatility, shifts in healthcare policy, and overall market sentiment surrounding the pharmaceutical sector.
	2025-04-23	-0.71 %	Thermo Fisher Scientific (TMO) stock fell by 0.71% amid concerns about a potential recession impacting the broader stock market.
Thermo Fisher Scientific (TMO) stock fell by 0.71% amid concerns about a potential recession impacting the broader stock market. Thermo Fisher Scientific's stock (TMO) declined by 0.71% amid general fluctuations in the medical sector, which is heavily influenced by trading volumes and market movements related to regulatory changes and innovation. Thermo Fisher Scientific (TMO) stock fell 0.71% to $417.34 amid a generally volatile biotech market characterized by high trading volumes and fluctuations, which often affects stock performance in this sector.
	2025-04-22	+3.05 %	Thermo Fisher Scientific (TMO) stock increased by 3.05% recently, likely due to positive developments and confidence shown by key investors in related companies like Banzai International, which announced significant capital-raising efforts and strong marketing technology solutions, suggesting overall market confidence in their sector.
Thermo Fisher Scientific (TMO) stock increased by 3.05% recently, likely due to positive developments and confidence shown by key investors in related companies like Banzai International, which announced significant capital-raising efforts and strong marketing technology solutions, suggesting overall market confidence in their sector.